Blood biomarkers and artificial intelligence: toward precision medicine in Alzheimer’s disease
The integration of blood-based biomarkers and artificial intelligence (AI) is revolutionizing the diagnostic landscape of Alzheimer’s disease (AD). In this paper, we synthesize recent advancements in the application of machine learning (ML) on blood biomarker analysis, evaluating their diagnostic efficacy and clinical...